Regenexx published its randomized controlled trial (RCT) mid-term results showing primary anterior cruciate ligament (ACL) healing without the need for...
The companies will work together for development and commercialization of Novosis rhBMP-2 bone growth materials and other solutions for the U.S. and Canada.